P3.03I.06 Neoadjuvant Gefitinib in EGFR Mutated NSCLC (a Phase 2 Window-Of-Opportunity Study): Deep Genomic and Transcriptomic Analysis

Saved in:
Bibliographic Details
Published inJournal of thoracic oncology Vol. 19; no. 10; p. S311
Main Authors Tan, A.C., Yeo, J.-C., Pang, M., Alvarez, J.J.S., Guo, A.Y., Hoo, R., Takano, A., Ong, B.-H., Yeong, J., Wu, Z., Yuan, J., S, S., Sim, N.L., Chua, K.P., Tam, W.L., Wang, L., Lau, D.P.X., Saw, S.P.L., Jain, A., Lai, G.G.Y., Tan, W.L., Ang, M.-K., Ng, Q.S., Kanesvaran, R., Lim, W.T., Skanderup, A.J., Tan, D.S.W.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.10.2024
Online AccessGet full text

Cover

More Information
ISSN:1556-0864
DOI:10.1016/j.jtho.2024.09.556